My A.I. Psychosis

My A.I. Psychosis

Tiny Eye Implants to End Reading Glasses Get a Second Shot at U.S. Approval

After an FDA panel voted against them in 2020, VisAbility's implants, already sold in Europe, are back in a new U.S. trial.

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 15, 2026
∙ Paid
Two friends talk over coffee in a café, a pair of reading glasses set aside on the table.

TL;DR

Refocus Group's VisAbility implants are tiny inserts placed in the white of the eye to give the eye's focusing muscle more room to work, with the goal of bringing back close-up reading vision without glasses. In a report from one site of an earlier U.S. trial, all 20 treated eyes read at 20/40 or better without glasses a year later. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: what the new trial measures, the earlier results, what happened at the FDA in 2020, our Odds board on 2 milestones, our labeled speculation, and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.